OLBA DVx HEALTHCARE INC.

OLBA DVx HEALTHCARE INC.

TTSE:2689
1,925.00
JPY
+16.00
(+0.84%)
12.12BMarket Cap
Oct 30Next Earn
OLBA DVx HEALTHCARE INC.
TSE:2689
(Tokyo Stock Exchange)

Recent

price

1,925.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
11,074.11
13,321.43
17,149.47
17,312.61
16,845.29
18,083.28
18,853.05
19,189.11
19,147.42
18,763.57
16,781.63
17,776.24
18,349.35
19,888.78
- -
- -
- -
Revenue per Share
55.65
61.67
168.12
145.54
72.23
54.49
123.1
187.86
138.24
56.76
162.66
252.8
234.9
251.68
- -
- -
- -
Basic EPS, GAAP
4.87
308.67
302.02
39.27
-472.96
23.99
125.52
-118.34
-72.51
70.79
409.92
323.93
-151.24
269.6
- -
- -
- -
Free Cash Flow per Basic Share
9.98
10
10.02
20
24.99
29.93
30
29.94
39.94
39.76
45.82
51.13
60.99
73.12
- -
- -
- -
Dividend per Share
363.55
407.18
578.43
699.75
839.59
818.77
942.77
1,121.32
1,191.62
1,197.17
1,336.91
1,513.91
1,712.18
1,922.58
- -
- -
- -
Book Value per Share
302.88
295.22
478.47
612.22
775.51
774.81
904.85
1,078.17
1,115.2
1,114.24
1,222.07
1,378.23
1,595.36
1,813.27
- -
- -
- -
Tangible Book Value per Share
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
Basic Weighted Avg Shares
62,136
74,745
96,223
97,138
94,515
101,461
105,779
107,664
107,428
107,897
102,072
107,959
110,473
118,565
- -
- -
- -
Sales/Revenue/Turnover
4.7
4.74
5.12
4.99
4.47
4.13
0.99
1.14
1.21
0.86
1.51
1.92
1.95
1.88
- -
- -
- -
Operating Margin (%)
267
332
365
361
396
397
312
316
362
410
402
403
510
565
- -
- -
- -
Depreciation Expense
312
346
943
817
405
306
691
1,054
776
326
989
1,535
1,414
1,500
- -
- -
- -
Net Income, GAAP
47.71
52.44
40.94
44.33
40.2
46.48
38.81
24.52
37.73
66.66
34.63
28.15
34.42
33.12
- -
- -
- -
Effective Tax Rate (%)
0.5
0.46
0.98
0.84
0.43
0.3
0.65
0.98
0.72
0.3
0.97
1.42
1.28
1.27
- -
- -
- -
Profit Margin (%)
96
536
539
1,135
942
1,110
1,776
2,132
2,666
2,928
2,986
4,042
5,148
5,871
- -
- -
- -
Working Capital
691
1,767
874
801
505
927
600
513
1,090
1,630
1,271
910
823
892
- -
- -
- -
LT Debt
2,040
2,285
3,245
3,926
4,711
4,594
5,426
6,417
6,771
7,282
8,132
9,093
10,328
11,374
- -
- -
- -
Total Equity
6.18
5.67
11.2
10.74
5.71
3.83
8.22
10.94
8.66
2.91
9.1
13.79
11.85
11.22
- -
- -
- -
Return on Invested Capital (%)
6.98
6.03
12.69
12.18
6.39
4.35
9.56
13.24
9.14
4.09
9.43
15.15
12.6
11.99
- -
- -
- -
Return on Capital (%)
16.42
16
34.11
22.77
9.38
6.57
13.98
18.2
11.95
4.67
12.84
17.83
14.56
13.83
- -
- -
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Mar'25
Dec'26
Mar'26
ST Debt
- -
2,350
- -
LT Borrowings
- -
1,317
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
12,957
12,123
12,401

Working Capital

JPY

•

in mil. unless spec.
Mar'25
Dec'26
Mar'26
Total Current Assets
- -
38,606
- -
Cash, Cash Equivalents & STI
- -
2,906
- -
Accounts Receivable, Net
- -
23,972
- -
Inventories
- -
7,396
- -
Total Current Liabilities
- -
32,301
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
2,350
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
27,496
29,970
31,936
29,163
118,565
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
27.9
53.16
106.35
65.11
251.68
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
73.12
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
OLBA HEALTHCARE HOLDINGS, Inc. operates as a holding company that, together with its subsidiaries, distributes medical equipment, pharmaceuticals and related products to hospitals, clinics, university research laboratories, nursing care facilities and other healthcare providers primarily in Japan. The company conducts its activities through three main segments: the Medical Equipment Business, which wholesales diagnostic imaging equipment such as MRI and CT scanners, operating room tools including shadowless lights and ventilators, surgical instruments like artificial joints, coronary stents, ultrasonic scalpels and osteosynthesis materials, cardiovascular catheters and pacemakers, endoscopes, life science reagents and equipment for genetic research, cell culture and protein analysis, as well as automatic analyzers and DNA analysis services; the Specialty Product Delivery (SPD) Business, which provides goods management, information management and purchase management services utilizing information technology systems such as HOSNET for inventory control and logistics at medical institutions; and the Nursing Care Products Business, which sells and rents welfare equipment including nursing beds, portable toilets, hearing aids and wheelchairs, alongside repair services and safety support for home care and long-term nursing. Founded in 1921 and headquartered in Okayama City, Japan, OLBA HEALTHCARE HOLDINGS maintains a nationwide network through subsidiaries like Kawanishi Co., Ltd. in the Chugoku-Shikoku and Hyogo regions, Nikko Medical Materials Co., Ltd. in the Kinki region, Sansei Medical Materials Co., Ltd. in the Tohoku region, HOSNET-JAPAN, Inc. for SPD solutions, Life Care Co., Ltd. for home care products, and Kawanishi BarcMed Co., Ltd. for ICT solutions targeting medical institutions. In recent developments, the company changed its name from Kawanishi Holdings, Inc. in January 2021 to mark its centennial, established a joint venture THAI OLBA Healthcare Co., Ltd. in January 2023 to enter the Thai market through distribution agreements with partners like Takazono Corporation for medical devices and collaborations with MORITOH Co., Ltd. for rehabilitation equipment as part of ASEAN expansion plans, introduced the Temasac series of automated settlement machines for clinics with 165 units deployed in the July-December 2024 period, expanded sales of the Medilia inventory management system in the Chugoku-Shikoku area, strengthened orthopedic and cardiovascular consumables sales via new customer acquisitions, and pursued wide-area growth in nursing care transactions including additional stores in the Seto Inland Area.